Enhanced efficiency of superoxide dismutase-induced cardioprotection by retrograde intracoronary administration.

[1]  M. Yacoub,et al.  Targeted Cell Delivery Into Infarcted Rat Hearts by Retrograde Intracoronary Infusion: Distribution, Dynamics, and Influence on Cardiac Function , 2004, Circulation.

[2]  G. Schuler,et al.  Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins: comparison with surgical and percutaneous intramyocardial gene delivery. , 2004, Journal of the American College of Cardiology.

[3]  Gerhard Steinbeck,et al.  Retroinfusion‐supported stenting in high‐risk patients for percutaneous intervention and bypass surgery: Results of the prospective randomized myoprotect I study , 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[4]  G. Moukarbel,et al.  Pharmacological therapy for myocardial reperfusion injury. , 2004, Current opinion in pharmacology.

[5]  M. Yacoub,et al.  Selective cell dissemination into the heart by retrograde intracoronary infusion in the rat. , 2004, Transplantation.

[6]  L. Becker.  New concepts in reactive oxygen species and cardiovascular reperfusion physiology. , 2004, Cardiovascular research.

[7]  M. Schwaiger,et al.  Selective pressure-regulated retroinfusion of fibroblast growth factor-2 into the coronary vein enhances regional myocardial blood flow and function in pigs with chronic myocardial ischemia. , 2003, Journal of the American College of Cardiology.

[8]  M. Majima,et al.  Bradykinin inhibits development of myocardial infarction through B2 receptor signalling by increment of regional blood flow around the ischaemic lesions in rats , 2003, British journal of pharmacology.

[9]  M. Entman,et al.  The inflammatory response in myocardial infarction. , 2002, Cardiovascular research.

[10]  M. Sheppard,et al.  Efficacy of adenoviral gene transfer with manganese superoxide dismutase and endothelial nitric oxide synthase in reducing ischemia and reperfusion injury. , 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[11]  L. Becker,et al.  Neutrophils are primary source of O2 radicals during reperfusion after prolonged myocardial ischemia. , 2001, American journal of physiology. Heart and circulatory physiology.

[12]  P. Ruengsakulrach,et al.  Anatomic and hemodynamic considerations influencing the efficiency of retrograde cardioplegia. , 2001, The Annals of thoracic surgery.

[13]  N. Dhalla,et al.  Status of myocardial antioxidants in ischemia-reperfusion injury. , 2000, Cardiovascular research.

[14]  P. Boekstegers,et al.  Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins , 2000, Gene Therapy.

[15]  O. Carretero,et al.  Echocardiographic assessment of cardiac function in conscious and anesthetized mice. , 1999, American journal of physiology. Heart and circulatory physiology.

[16]  Y. Kaneda,et al.  Myocardial protection with endogenous overexpression of manganese superoxide dismutase. , 1999, The Annals of thoracic surgery.

[17]  Steven P Jones,et al.  Myocardial ischemia-reperfusion injury in CD18- and ICAM-1-deficient mice. , 1998, American journal of physiology. Heart and circulatory physiology.

[18]  P. Boekstegers,et al.  Selective suction and pressure-regulated retroinfusion: an effective and safe approach to retrograde protection against myocardial ischemia in patients undergoing normal and high risk percutaneous transluminal coronary angioplasty. , 1998, Journal of the American College of Cardiology.

[19]  P. Wong,et al.  Overexpression of human copper, zinc-superoxide dismutase (SOD1) prevents postischemic injury. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[20]  D. Lefer,et al.  Myocardial ischemia-reperfusion injury in CD18- and ICAM-1-deficient mice. , 1998, American journal of physiology. Heart and circulatory physiology.

[21]  E. Topol,et al.  Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction. , 1994, Circulation.

[22]  J O'Keefe,et al.  A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction , 1993 .

[23]  M. Chiariello,et al.  The effects of calcium channel antagonist treatment and oxygen radical scavenging on infarct size and the no-reflow phenomenon in reperfused hearts. , 1993, American heart journal.

[24]  C. Kawai,et al.  Effects of superoxide dismutase on reperfusion arrhythmias and left ventricular function in patients undergoing thrombolysis for anterior wall acute myocardial infarction. , 1991, The American journal of cardiology.

[25]  R. Jennings,et al.  Therapy to reduce free radicals during early reperfusion does not limit the size of myocardial infarcts caused by 90 minutes of ischemia in dogs. , 1988, Circulation.

[26]  P. J. Simpson,et al.  Sustained Limitation by Superoxide Dismutase of Canine Myocardial Injury Due to Regional Ischemia Followed by Reperfusion , 1988, Journal of cardiovascular pharmacology.

[27]  R. Jennings,et al.  Failure of superoxide dismutase to limit size of myocardial infarction after 40 minutes of ischemia and 4 days of reperfusion in dogs. , 1987, Circulation.

[28]  M. Weisfeldt,et al.  Direct measurement of free radical generation following reperfusion of ischemic myocardium. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. Weisfeldt,et al.  Reduction in experimental infarct size by recombinant human superoxide dismutase: insights into the pathophysiology of reperfusion injury. , 1986, Circulation.

[30]  A. Buda,et al.  Failure of superoxide dismutase and catalase to alter size of infarction in conscious dogs after 3 hours of occlusion followed by reperfusion. , 1986, Circulation.

[31]  B. Pitt,et al.  The independent effects of oxygen radical scavengers on canine infarct size. Reduction by superoxide dismutase but not catalase. , 1985, Circulation research.

[32]  B. Lucchesi,et al.  Canine Myocardial Reperfusion Injury: Its Reduction by the Combined Administration of Superoxide Dismutase and Catalase , 1984, Circulation research.